Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 82,700 | 51,800 | 27,500 | 360,300 | 339,800 |
| Depreciation Amortization | 155,700 | 101,800 | 49,000 | 194,100 | 138,000 |
| Income taxes - deferred | -29,300 | -27,300 | 700 | -6,100 | -46,100 |
| Accounts receivable | 10,400 | 22,100 | 33,500 | 9,200 | 51,100 |
| Accounts payable and accrued liabilities | -82,000 | -18,200 | -62,400 | 15,000 | -59,800 |
| Other Working Capital | -112,600 | 15,000 | -15,000 | 265,400 | 258,900 |
| Other Operating Activity | 102,200 | 11,300 | 37,900 | -384,500 | -8,500 |
| Operating Cash Flow | $127,100 | $156,500 | $71,200 | $453,400 | $673,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95,500 | -67,300 | -24,800 | -73,800 | -50,100 |
| Net Acquisitions | -211,800 | -210,300 | -1,000 | 27,100 | -1,500 |
| Purchase Of Investment | 0 | 0 | 0 | -1,100 | -800 |
| Sale Of Investment | N/A | N/A | N/A | 347,600 | 28,600 |
| Other Investing Activity | -400 | -400 | -400 | 0 | 0 |
| Investing Cash Flow | $-307,700 | $-278,000 | $-26,200 | $299,800 | $-23,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -5,000 | N/A | N/A |
| Debt Issued | 218,900 | 18,900 | 193,400 | N/A | N/A |
| Debt Repayment | -217,900 | -12,300 | -148,800 | -22,600 | -17,100 |
| Common Stock Issued | 500 | 500 | 13,900 | 15,600 | 15,300 |
| Common Stock Repurchased | N/A | N/A | N/A | -400 | N/A |
| Dividend Paid | -138,100 | -92,100 | -46,000 | -485,100 | -439,100 |
| Other Financing Activity | -4,900 | -4,900 | 100 | 12,300 | 11,800 |
| Financing Cash Flow | $-141,500 | $-89,900 | $7,600 | $-480,200 | $-429,100 |
| Beginning Cash Position | 435,200 | 435,200 | 435,200 | 162,200 | 162,200 |
| End Cash Position | 113,100 | 223,800 | 487,800 | 435,200 | 382,700 |
| Net Cash Flow | $-322,100 | $-211,400 | $52,600 | $273,000 | $220,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 127,100 | 156,500 | 71,200 | 453,400 | 673,400 |
| Capital Expenditure | -99,100 | -70,600 | -24,800 | -114,400 | -82,000 |
| Free Cash Flow | 28,000 | 85,900 | 46,400 | 339,000 | 591,400 |